Related references
Note: Only part of the references are listed.Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade
Yu Saida et al.
CANCER RESEARCH (2021)
Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1
Kristin L. Granlund et al.
CELL METABOLISM (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Hyperpolarized C-13 MRI: Path to Clinical Translation in Oncology
John Kurhanewicz et al.
NEOPLASIA (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients
Vesselin Z. Miloushev et al.
CANCER RESEARCH (2018)
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies (vol 58, pg 22, 2017)
Jeong A. Park et al.
CANCER TREATMENT REVIEWS (2017)
Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization
Kayvan R. Keshari et al.
CHEMICAL SOCIETY REVIEWS (2014)
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate
Sarah J. Nelson et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Magnetic resonance imaging with hyperpolarized [1,4-13C2]fumarate allows detection of early renal acute tubular necrosis
Menna R. Clatworthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Share Paper
